All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
ZN-c3-002
The purpose of this study is to test a potential new treatment for ovarian, peritoneal or fallopian tube cancer called ZN-c3-also known as azenosertib.
ZOvCa - A phase 1 PET-CT study of 89Zr-hu/mo-10D7 in patients with advanced epithelial Ovarian Cancer
The primary aim of this clinical trial is to test the safety of a new imaging agent in patients with epithelial ovarian cancer.